http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
이치연,이동주,조이수,김승인,이지연,김은철 원광대학교 생체재료·매식연구소 1996 원광생체재료·매식 Vol.5 No.2
Dens evaginatus is a rare developmental anomaly in which an enamel-covered tubercle projects from the occlusal surface of a tooth. usually lower second premolar. When the tubercle fractures, the pulpal extension into the tubercle may be exposed, which results in early pulpal necrosis, periapical infection and even osteomyelitis. We found the dens evaginatus in 16-week-old fetal mandible. Microscopically, we observed the protrusion of dental papilla into the dental organ and hard tissue formation which will be the tubercle by serial section. This anomaly was reported to be very rare in tooth development of fetus, so we reported this finding with brief review of literatures.
甚한 喉頭腫瘍을 隨伴한 Weber-Christian氏病의 1例
朴祥用,李正煥,盧寬澤,吳仁錫,池堤根 中央醫學社 1940 中央醫學 Vol.9 No.5
Authors experienced a case considered as Weber-Christian disease by clinical symptoms and histopathological findings, which was accompanied with severe pharyngeal ulceration and massive bleeding from the pharyngeal wall. The case, 54 years old Korean woman, admitted in this hospital because of sore throat, dysphagia, anorexia, and general weakness. During hospitalization, recurrent subcutaneous nodules were noticed on the areas of left breast, flexor side of right forearm, and both inner thighs and intermittent high fever continued. Histological examinations of the subcutaneous nodules were reported to be consistent with the findings of Weber-Christian disease. The patient was expired on the 42nd hospital day without any response to penicillin, sulfa drugs, and corticosteroids administration.
Lee, M-G,Huh, J-S,Chung, S-K,Lee, J-H,Byun, D-S,Ryu, B-K,Kang, M-J,Chae, K-S,Lee, S-J,Lee, C-H,Kim, J I,Chang, S-G,Chi, S-G Nature Publishing Group 2006 Oncogene Vol.25 No.42
XIAP-associated factor 1 (XAF1) is a new candidate tumor suppressor, which has been known to exert proapoptotic effects by interfering with the caspase-inhibiting activity of XIAP. To explore the XAF1's candidacy for a suppressor in urogenital tumorigenesis, we investigated the XAF1 status in a series of cancer cell lines and primary tumors derived from the bladder, kidney and prostate. Expression of XAF1 transcript was undetectable or extremely low in 60% (3/5) of bladder, 66% (10/15) of kidney, and 100% (3/3) prostate cancer cell lines. Abnormal reduction of XAF1 was also found in 33% (18/55) of primary bladder and 40% (8/20) of primary kidney tumors, and showed a correlation with advanced stage and high grade of bladder tumor. Hypermethylation at 14 CpG sites in the 5′ proximal region of the XAF1 promoter was highly prevalent in cancers versus adjacent normal or benign tissues and tightly associated with reduced gene expression. XAF1 expression enhanced the apoptotic response of tumor cells to chemotherapeutic agents, such as etoposide or 5-FU. While XAF1 expression did not influence the subcellular distribution or expression of XIAP, it elevated the protein stability of p53 and its target gene expression. Moreover, the apoptosis-sensitizing and growth suppression function of XAF1 was markedly impeded by blockade of p53 function. Collectively, our study demonstrates that epigenetic alteration of XAF1 is frequent in human urogenital cancers and may contribute to the malignant progression of tumors by rendering tumor cells a survival advantage partially through the attenuated p53 response to apoptotic stresses.Oncogene (2006) 25, 5807–5822. doi:10.1038/sj.onc.1209867; published online 7 August 2006
Lee, J-H,Lee, J-H,Lim, S-N,Kim, D-Y,Kim, S H,Lee, Y-S,Kang, Y-A,Kang, S-I,Jeon, M J,Seol, M,Seo, E-J,Chi, H S,Park, C J,Jang, S,Yun, S-C,Lee, K-H Macmillan Publishers Limited 2010 BONE MARROW TRANSPLANTATION -BASINGSTOKE- Vol.45 No.3
We analyzed the clinical significance of pre-transplant International Prognostic Scoring System (IPSS) score and comorbidity in 68 patients who underwent allogeneic hematopoietic cell transplantation (HCT) for myelodysplastic syndrome (MDS) (n=48) or acute myeloid leukemia evolved from MDS (n=20) between December 1995 and January 2008 in a single institute. During a median follow-up period of 41.0 months (range, 3.2–132.0 months), 27 patients died, and 7 relapsed. The 5-year probabilities of overall survival (OS) and event-free survival (EFS) were 60.0 and 57.4%, respectively, and the 5-year cumulative incidences of non-relapse mortality (CINRM) and relapse were 32.7 and 9.9%, respectively. OS, EFS, and CINRM were significantly different according to pre-transplant IPSS score and presence of pre-transplant comorbidity, which were independent risk factors along with Karnofsky performance score in multivariate analyses. In conclusion, pre-transplant IPSS score and comorbidity may stratify the risk of post transplant outcomes in MDS.
Chi, L.,Na, M.H.,Jung, H.K.,Vadevoo, S.M.P.,Kim, C.W.,Padmanaban, G.,Park, T.I.,Park, J.Y.,Hwang, I.,Park, K.U.,Liang, F.,Lu, M.,Park, J.,Kim, I.S.,Lee, B.H. Elsevier Science Publishers 2015 Journal of controlled release Vol.209 No.-
A growing body of evidence suggests that pathological lesions express tissue-specific molecular targets or biomarkers within the tissue. Interleukin-4 receptor (IL-4R) is overexpressed in many types of cancer cells, including lung cancer. Here we investigated the properties of IL-4R-binding peptide-1 (IL4RPep-1), a CRKRLDRNC peptide, and its ability to target the delivery of liposomes to lung tumor. IL4RPep-1 preferentially bound to H226 lung tumor cells which express higher levers of IL-4R compared to H460 lung tumor cells which express less IL-4R. Mutational analysis revealed that C1, R2, and R4 residues of IL4RPep-1 were the key binding determinants. IL4RPep-1-labeled liposomes containing doxorubicin were more efficiently internalized in H226 cells and effectively delivered doxorubicin into the cells compared to unlabeled liposomes. In vivo fluorescence imaging of nude mice subcutaneously xenotransplanted with H226 tumor cells indicated that IL4RPep-1-labeled liposomes accumulate more efficiently in the tumor and inhibit tumor growth more effectively compared to unlabeled liposomes. Interestingly, expression of IL-4R was high in vascular endothelial cells of tumor, while little was detected in vascular endothelial cells of control organs including the liver. IL-4R expression in cultured human vascular endothelial cells was also up-regulated when activated by a pro-inflammatory cytokine tumor necrosis factor-α. Moreover, the up-regulation of IL-4R expression was observed in primary human lung cancer tissues. These results indicate that IL-4R-targeting nanocarriers may be a useful strategy to enhance drug delivery through the recognition of IL-4R in both tumor cells and tumor endothelial cells.
He, X.,Bonaparte, N.,Kim, S.,Acharya, B.,Lee, J.Y.,Chi, L.,Lee, H.J.,Paik, Y.K.,Moon, P.G.,Baek, M.C.,Lee, E.K.,Kim, J.H.,Kim, I.S.,Lee, B.H. Elsevier Science Publishers 2012 Journal of controlled release Vol.162 No.3
Chemotherapy-induced apoptosis of tumor cells enhances the antigen presentation and sensitizes tumor cells to T cell-mediated cytotoxicity. Here we harnessed the apoptosis of tumor cells as a homing signal for the delivery of T cells to tumor. Jurkat T cells were anchored with ApoPep-1, an apoptosis-targeted peptide ligand, using the biocompatible anchor for membrane (BAM), an oleyl acid derivative. The ApoPep-1-BAM conjugate was efficiently anchored to cell membrane, while little anchoring was obtained with ApoPep-1 alone. The retention period of the ApoPep-1-BAM conjugate on cell membrane was approximately 80 and 40min in the absence and presence of serum, respectively. ApoPep-1 was resistant to degradation in serum until 2h. The apoptosis-targeted T cells that were anchored with the ApoPep-1-BAM preferentially bound to apoptotic tumor cells over living cells. When intravenously injected into tumor-bearing mice, the number of apoptosis-targeted T cells and in vivo fluorescence signals by the homing of the cells to doxorubicin-treated tumor were higher than those of untargeted T cells. Accumulation of apoptosis-targeted T cells at other organs such as liver was not detected. These results suggest that the chemotherapy-induced apoptosis and subsequent enhancement of T cell delivery to tumor by the membrane anchoring of the apoptosis-targeted peptide could be a novel strategy for cancer immunotherapy.
Chi, Y.H.,Kim, S.Y.,Jung, I.J.,Shin, M.R.,Jung, Y.J.,Park, J.H.,Lee, E.S.,Maibam, P.,Kim, K.S.,Park, J.H.,Kim, M.J.,Hwang, G.Y.,Lee, S.Y. North-Holland Pub ; Elsevier Science Ltd 2012 FEBS letters Vol.586 No.19
Based on the fact that the amino acid sequence of sulfiredoxin (Srx), already known as a redox-dependent sulfinic acid reductase, showed a high sequence homology with that of ParB, a nuclease enzyme, we examined the nucleic acid binding and hydrolyzing activity of the recombinant Srx in Arabidopsis (AtSrx). We found that AtSrx functions as a nuclease enzyme that can use single-stranded and double-stranded DNAs as substrates. The nuclease activity was enhanced by divalent cations. Particularly, by point-mutating the active site of sulfinate reductase, Cys (72) to Ser (AtSrx-C72S), we demonstrate that the active site of the reductase function of AtSrx is not involved in its nuclease function.